Tracking cancer drugs in living cells by thermal profiling of the proteome
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Mapping human drug targets in the cell: To understand both the beneficial and the side effects of a drug, one would need to know its full binding profile to all cellular proteins. Savitski et al. take significant steps toward meeting this daunting challenge. They monitored the unfolding or “melting” of over 7000 human proteins and measured how small-molecule binding changes individual melting profiles. As a proof of principle, over 50 targets were identified for an inhibitor known to bind a broad spectrum of kinases. Two cancer drugs, vemurafib and Alectinib, are known to have a side effect of photosensitivity. The thermal profiling approach identified drug-protein interactions responsible for these side effects. Science , this issue 10.1126/science.1255784
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thermal proteome profiling (TPP, Savitski et al, 2014) is a mass-spectrometry (MS) based functional proteomics method that can identify shifts in protein thermal stability across different conditions (Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“Especially in combination with quantitative changes measured by e.g., phosphoproteomics, TPP can be used to identify functionally relevant alterations and link them to signaling and phenotypic consequences (Savitski et al, 2014; Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“TPP has been used successfully in the past for drug profiling, but it generates complex data that are difficult to interpret and potentially benefit from integration with other data types (Savitski et al, 2014; Perrin et al, 2020; Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“Thermal stabilization (i) is leveraged in thermal proteomics profiling (TPP), an approach that has been employed to, for instance, identify the ferrochelatase FECH as a frequent off-target of kinase inhibitors,224 or to uncover leucine aminopeptidase 3 as an off-target of several HDAC inhibitors.225”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [224]
In the citing paper
“This assay is based on the concept that binding of a compound to a protein can result in thermal stabilization of the protein and-consequently-in a detectable shift of its melting curve.”
From Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer (2021) · cites this paper as Savitski et al., 2014
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eden, E., Navon, R., Steinfeld, I., Lipson, D., & Yakhini, Z. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-48 · Cited by 3,356
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Self-citationDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Bollag, G., Hirth, P., Tsai, J., Zhang, J., Ibrahim, P. N., Cho, H., Spevak, W., Zhang, C., Zhang, Y., Habets, G., et al. (2010) · Nature · doi:10.1038/nature09454 · Cited by 1,831
Mass-spectrometry-based draft of the human proteome
Wilhelm, M., Schlegl, J., Hahne, H., Gholami, A. M., Lieberenz, M., Savitski, M. M., Ziegler, E., Butzmann, L., Gessulat, S., Marx, H., et al. (2014) · Nature · doi:10.1038/nature13319 · Cited by 1,820
Self-citationOverriding Imatinib Resistance with a Novel ABL Kinase Inhibitor
Shah, N. P., Tran, C., Lee, F. Y., Chen, P., Norris, D., & Sawyers, C. L. (2004) · Science · doi:10.1126/science.1099480 · Cited by 1,796
Kulak, N. A., Pichler, G., Paron, I., Nagaraj, N., & Mann, M. (2014) · Nature Methods · doi:10.1038/nmeth.2834 · Cited by 1,719
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1328 · Cited by 1,034
Self-citation
Cited by
Items 501–600 of 1,004
Functionalizing tandem mass tags for streamlining click-based quantitative chemoproteomics
Burton, N. R., & Backus, K. M. (2024) · Communications Chemistry · doi:10.1038/s42004-024-01162-x · Cited by 22
Jiang, Y., DeBord, D., Vitrac, H., Stewart, J., Haghani, A., Eyk, J. E. V., Fert‐Bober, J., & Meyer, J. G. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00248 · Cited by 18
Emerging affinity methods for protein-drug interaction analysis
Zheng, X., Zhu, H., Zhao, X., Wang, J., Li, Q., & Zhao, X. (2024) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2024.116371 · Cited by 18
High-throughput identification of calcium-regulated proteins across diverse proteomes
Locke, T. M., Fields, R., Gizinski, H., Otto, G. M., MacEwen, M. J. S., Rusnac, D.-V., He, P., Shechner, D. M., McGann, C. D., Berg, M. D., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114879 · Cited by 17
Ding, Y., Ball, K. A., Webb, K. J., Gao, Y., D’Alessandro, A., Old, W. M., Stowell, M. H. B., & Ding, X. (2020) · Small · doi:10.1002/smll.202003506 · Cited by 19
Gholizadeh, E., Karbalaei, R., Khaleghian, A., Salimi, M., Gilany, K., Soliymani, R., Tanoli, Z., Rezadoost, H., Baumann, M., Jafari, M., et al. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.120.000210 · Cited by 19
Benedé, S., Lozano‐Ojalvo, D., Cristóbal, S., Costa, J. S., D'Auria, E., Veličković, T. Ć., Garrido‐Arandia, M., Karakaya, S., Mafra, I., Mazzucchelli, G., et al. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1931806 · Cited by 17
“The supernatants are analyzed by MS to generate the melting curves of the target proteins (Savitski et al. 2014; Franken et al. 2015).”
BackgroundHigh-Content Screening Pipeline for Natural Products Targeting Oncogenic Signaling in Melanoma
Dürr, L., Hell, T., Dobrzyński, M., Mattei, A., John, A., Augsburger, N., Bradanini, G., Reinhardt, J. K., Rossberg, F., Drobnjaković, M., et al. (2022) · Journal of Natural Products · doi:10.1021/acs.jnatprod.1c01154 · Cited by 19
Profiling of Small Molecules by Chemical Proteomics
Huber, K., & Superti‐Furga, G. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3341-9_15 · Cited by 18
Quantitative chemoproteomics reveals dopamine’s protective modification of Tau
Wang, Q., Liu, Z., Wang, Y. S., Liu, Y., Chen, Y., Zhang, S., Zeng, W., Li, D., Yang, F., He, Z., et al. (2025) · Nature Chemical Biology · doi:10.1038/s41589-025-01849-9 · Cited by 21
Detomasi, T. C., Degotte, G., Huang, S., Suryawanshi, R. K., Diallo, A., Lizzadro, L., Belinchón, F. J. Z., Taha, T. Y., Li, J., Richards, A., et al. (2025) · Science Advances · doi:10.1126/sciadv.adt7836 · Cited by 20
“To evaluate the selectivity of AVI-4516 across the cellular proteome, we turned to thermal proteome profiling (TPP) ( 39 ).”
Xu, X., Li, H., Lin, H., Li, Q., Liu, Y., Huang, W., Yang, J., Li, N., Gao, Z., Wang, S., et al. (2026) · Hepatology · doi:10.1097/hep.0000000000001429 · Cited by 16
“[40]”
Next-generation sequencing: hype and hope for development of personalized radiation therapy?
Tinhofer, I., Niehr, F., Konschak, R., Liebs, S., Munz, M., Stenzinger, A., Weichert, W., Keilholz, U., & Budach, V. (2015) · Radiation Oncology · doi:10.1186/s13014-015-0481-x · Cited by 18
“The application of these techniques will not only allow the monitoring of proteinprotein interactions, posttranslational modification and drug-target engagement directly in cells or tissues but will also represent a valuable tool for identifying off-target drug effects [80].”
BackgroundSite-Specific Activity-Based Protein Profiling Using Phosphonate Handles
van Bergen, W., Hevler, J. F., Wu, W., Baggelaar, M. P., & Heck, A. J. R. (2022) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2022.100455 · Cited by 21
Challenges and Perspectives in Target Identification and Mechanism Illustration for Chinese Medicine
Guo, X., An, S., Bao, F., & Xu, T. (2023) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-023-3629-9 · Cited by 19
“TPP can identify proteins that exhibit ligand-induced thermal stability at higher temperatures combined with multiplexed quantitative MS to estimate ligand–target engagement on a cellular proteomic scale.((41))”
BackgroundProtein‐Metabolite Interactions: Discovery and Significance
Dixit, A., & Kalia, J. (2023) · ChemBioChem · doi:10.1002/cbic.202200755 · Cited by 16
Yu, H., Chen, Y., Wang, Y., Fu, W., Xu, R., Liu, J., Chen, Y., Liu, X., Wu, Y., & Xu, T. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c03398 · Cited by 18
Dextromethorphan inhibits collagen and collagen-like cargo secretion to ameliorate lung fibrosis
Khan, M. M., Galea, G., Jung, J. E., Zukowska, J., Lauer, D., Tuechler, N., Halavatyi, A. A., Tischer, C., Haberkant, P., Stein, F., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adj3087 · Cited by 16
Self-citationZhang, C., Cui, M., Cui, Y., Hettinghouse, A., & Liu, C.-J. (2019) · Journal of Visualized Experiments · doi:10.3791/59656 · Cited by 20
Proteomics-based target identification of natural products affecting cancer metabolism
Muroi, M., & Osada, H. (2021) · The Journal of Antibiotics · doi:10.1038/s41429-021-00437-y · Cited by 17
Past accomplishments and future challenges of the multi-omics characterization of leaf growth
Skirycz, A., & Fernie, A. R. (2022) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiac136 · Cited by 16
“ing [TPP]/CETSA) (Savitski et al., 2014; Franken et al., 2015), susceptibility to proteolytic cleavage (DARTS/Lip-MS) (Feng”
Hidden information on protein function in censuses of proteome foldedness
Cox, D., Ang, C.-S., Nillegoda, N. B., Reid, G. E., & Hatters, D. M. (2022) · Nature Communications · doi:10.1038/s41467-022-29661-2 · Cited by 16
“(15), Savitski et al., 2014, Science.”
Li, Z., Lin, Y., Huang, Y., Liu, R., Zhan, C., Wang, X., & Luo, H. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2024937118 · Cited by 16
Yan, C., Gu, X.-Y., Tan, S., Mei, A.-Y., Mao, J.-H., Dai, Y., Niu, J., Li, W., Kurihara, H., Li, Y.-F., et al. (2025) · Food Research International · doi:10.1016/j.foodres.2025.115900 · Cited by 25
Proteome-Wide Deconvolution of Drug Targets and Binding Sites by Lysine Reactivity Profiling
Ruan, C., Zhou, J., Li, Z., Li, K., Fang, Z., Zhang, X., & Ye, M. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c05455 · Cited by 14
Ibarra‐Meneses, A. V., Corbeil, A., Wagner, V., Beaudry, F., do Monte‐Neto, R. L., & Fernandez‐Prada, C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.954144 · Cited by 16
“Of note, our experiments were conducted on cell extracts where ligand binding but no downstream or feedback effects occur (Savitski et al., 2014).”
MethodMerits of Diazirine Photo-Immobilization for Target Profiling of Natural Products and Cofactors
Prokofeva, P., Höfer, S., Hornisch, M., Abele, M., Küster, B., & Médard, G. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00500 · Cited by 18
Fang, M., Wu, O., Cupp‐Sutton, K. A., Smith, K., & Wu, S. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c04266 · Cited by 15
A Shift in Thinking: Cellular Thermal Shift Assay-Enabled Drug Discovery
Caballero, I. M., & Lundgren, S. (2023) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.2c00545 · Cited by 15
Phaneuf, C. G., Aizikov, K., Grinfeld, D., Kreutzmann, A., Mourad, D., Lange, O., Dai, D., Zhang, B., Belenky, A., Makarov, A., et al. (2023) · Communications Chemistry · doi:10.1038/s42004-023-00861-1 · Cited by 17
Shanley, H. T., Taki, A. C., Byrne, J. J., Nguyen, N., Wells, T. N. C., Jabbar, A., Sleebs, B. E., & Gasser, R. B. (2024) · Parasites & Vectors · doi:10.1186/s13071-024-06183-y · Cited by 17
The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2
Suryawanshi, R. K., Jaishankar, P., Correy, G. J., Rachman, M. M., O’Leary, P. C., Taha, T. Y., Matsui, Y., Belinchón, F. J. Z., McCavitt-Malvido, M., Doruk, Y. U., et al. (2025) · eLife · doi:10.7554/elife.103484.3 · Cited by 17
A kalihinol analog disrupts apicoplast function and vesicular trafficking in P. falciparum malaria
Chahine, Z. M., Abel, S., Hollin, T., Chung, J., Barnes, G., Daub, M. E., Renard, I., Choi, J., Vydyam, P., Pal, A. C., et al. (2024) · Science · doi:10.1126/science.adm7966 · Cited by 20
“The data were processed using the mineCETSA R package (49), from which melting curves were generated for >800 P. falciparum proteins (table S6 and supporting information S2) (50, 51).”
Coupling cellular drug-target engagement to downstream pharmacology with CeTEAM
Valerie, N. C. K., Sanjiv, K., Mortusewicz, O., Zhang, S. M., Alam, S., Pires, M. J., Stigsdotter, H., Rasti, A., Langelier, M.-F., Rehling, D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54415-7 · Cited by 16
Mass spectrometry methods to study protein-metabolite interactions
Guo, H., Peng, H., & Emili, A. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1378178 · Cited by 17
“In a pioneering proof-of-principle study, TPP was used to identify hundreds of human proteins that bind to a dominant endogenous cellular metabolite, ATP [31].”
BackgroundScheele, S., Geiger, J. A., DeRocher, A. E., Choi, R., Smith, T. R., Hulverson, M. A., Vidadala, R. S. R., Barrett, L. K., Maly, D. J., Merritt, E. A., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00051-18 · Cited by 15
Proteomic Technologies for Deciphering Local and Global Protein Interactions
Greco, T. M., Kennedy, M. A., & Cristea, I. M. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.01.003 · Cited by 15
Yu, K., Niu, M., Wang, H., Li, Y., Wu, Z., Zhang, B., Haroutunian, V. H., & Peng, J. (2021) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.0c00450 · Cited by 16
EFMC: Trends in Medicinal Chemistry and Chemical Biology
Auberson, Y. P., Arimondo, P. B., Duca, M., Essig, S., Grether, U., Rufer, A. C., Sbardella, G., Schopfer, U., Torrens, A., van der Stelt, M., et al. (2023) · ChemBioChem · doi:10.1002/cbic.202200690 · Cited by 18
Jin, L., Wang, D., Gooden, D. M., Ball, C. H., & Fitzgerald, M. C. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b02658 · Cited by 15
Benchmarking of Quantitative Proteomics Workflows for Limited Proteolysis Mass Spectrometry
Koudelka, T., Bassot, C., & Piazza, I. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.100945 · Cited by 16
Decoding protein methylation function with thermal stability analysis
Sayago, C., Sánchez, J., García, F., Hurtado, B., Lafarga, V., Prieto, P., Zarzuela, E., Ximénez‐Embún, P., Ortega, S., Megías, D., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38863-1 · Cited by 18
Toward the analysis of functional proteoforms using mass spectrometry-based stability proteomics
Kang, J., Seshadri, M., Cupp‐Sutton, K. A., & Wu, S. (2023) · Frontiers in Analytical Science · doi:10.3389/frans.2023.1186623 · Cited by 14
“…and the melting curve for each protein is fit using diverse methods/software packages that can determine melting point shifts and melting behavior similarities (Savitski et al, 2014; Leuenberger et al, 2017; Childs et al, 2019; Mateus et al, 2020a; Kurzawa et al, 2020; Fang et al, 2021b).”
MethodRuwolt, M., Piazza, I., & Liu, F. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102648 · Cited by 15
Chaperone mediated detection of small molecule target binding in cells
Cho, K. F., Ma, T. P., Rose, C. M., Kirkpatrick, D. S., Yu, K., & Blake, R. A. (2020) · Nature Communications · doi:10.1038/s41467-019-14033-0 · Cited by 14
Discovery–Versus Hypothesis–Driven Detection of Protein–Protein Interactions and Complexes
Bludau, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094450 · Cited by 12
“TPP is a method to systematically measure protein thermal stability and abundance [29].”
MethodExperimental methods for dissecting the terraincognita of protein-metabolite interactomes
Wagner, M. M., Zhang, B., Tauffenberger, A., Schroeder, F. C., & Skirycz, A. (2021) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2021.100403 · Cited by 15
Mechanistic Insights into a CDK9 Inhibitor Via Orthogonal Proteomics Methods
Hendricks, J. A., Beaton, N., Chernobrovkin, A. L., Miele, E., Hamza, G. M., Ricchiuto, P., Tomlinson, R., Friman, T., Borenstain, C., Barlaam, B. C., et al. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00488 · Cited by 14
Self-citationOrthogonally-tunable and ER-targeting fluorophores detect avian influenza virus early infection
Kang, T., Haque, M. M., Lee, B., Hong, K. T., Hong, S. C., Kim, Y., Lee, J., Lee, J., & Lee, D. (2022) · Nature Communications · doi:10.1038/s41467-022-33586-1 · Cited by 15
Chemical Biology Approaches Confirm MCT4 as the Therapeutic Target of a Cellular Optimized Hit
Kawatkar, A., Clark, R., Hopcroft, L., Roaquin, D. A., Tomlinson, R., Zuhl, A. M., Lamont, G. M., Kettle, J. G., Critchlow, S. E., Castaldi, M. P., et al. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.2c00666 · Cited by 14
Zeng, L., Shin, W., Zhu, X., Park, S. H., Park, C., Tao, W. A., & Kihara, D. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00624 · Cited by 13
Effect of Sec61 interaction with Mpd1 on endoplasmic reticulum-associated degradation
Pereira, F., Rettel, M., Stein, F., Savitski, M. M., Collinson, I. R., & Römisch, K. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211180 · Cited by 12
“Mass Spectrometry Sample preparation The whole lane of each samples was cut out into small cubes and subjected to in-gel digestion with trypsin (Savitski et al., 2014).”
MethodSelf-citationHerlédan, A., Andres, M., Lejeune-Dodge, A., Leroux, F., Biela, A., Piveteau, C., Warenghem, S., Couturier, C., Deprez, B. P., & Deprez-Poulain, R. F. (2019) · SLAS DISCOVERY · doi:10.1177/2472555219897256 · Cited by 14
Jörg, M., & Madden, K. S. (2021) · RSC Medicinal Chemistry · doi:10.1039/d1md00022e · Cited by 15
Ma, M., Chu, Z., Quan, H., Li, H., Zhou, Y., Han, Y., Li, K., Pan, W., Wang, D., Yan, Y., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1524654 · Cited by 22
“…target deconvolution techniques like thermal proteome pro fi ling (TPP) allow global analysis of thermal stability shifts across 7,000+ proteins (Savitski et al., 2014), as demonstrated by the discovery that CDC42 inhibitors stabilize β - catenin/E-cadherin complexes to suppress renal fi…”
Yang, C., Kang, Y., Zhu, C.-Y., Ma, Y., Yu, P., Yang, T., Liu, Y.-Q., Zhang, Z.-Y., Suzuki, N., Ogra, Y., et al. (2025) · Leukemia · doi:10.1038/s41375-025-02709-0 · Cited by 14
“These fi ndings reinforce the idea that drug treatments also in fl uence the thermal stability of downstream signaling effectors through disrupting protein interactions rather than direct binding with these proteins [45, 46].”
Goroshchuk, O., Kolosenko, I., Kunold, E., Vidarsdóttir, L., Pirmoradian, M., Azimi, A., Jafari, R., & Palm‐Apergi, C. (2021) · The FASEB Journal · doi:10.1096/fj.202100457rr · Cited by 12
Self-citationCellular Target Deconvolution of Small Molecules Using a Selection-Based Genetic Screening Platform
Zhao, J., Tang, Z., Selvaraju, M., Johnson, K. A., Douglas, J. T., Gao, P. F., Petrassi, H. M., Wang, M. Z., & Wang, J. (2022) · ACS Central Science · doi:10.1021/acscentsci.2c00609 · Cited by 13
Ye, Y., Li, K., Ma, Y., Zhang, X., Li, Y., Yu, T., Wang, Y., & Ye, M. (2023) · Molecules · doi:10.3390/molecules28124859 · Cited by 15
“Considering that drug binding typically increases the stability of target proteins [8], we only considered proteins that displayed increased stabilities as candidate target proteins.”
BackgroundMethodTranslating Senotherapeutic Interventions into the Clinic with Emerging Proteomic Technologies
Dey, A. K., Banarjee, R., Boroumand, M., Rutherford, D. V., Strassheim, Q., Nyunt, T., Olinger, B., & Basisty, N. (2023) · Biology · doi:10.3390/biology12101301 · Cited by 14
Shanley, H. T., Taki, A. C., Nguyen, N. H., Wang, T., Byrne, J. J., Ang, C., Leeming, M. G., Nie, S., Williamson, N. A., Zheng, Y., et al. (2024) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2024.100522 · Cited by 13
“Here, we modelled the three-dimensional structures of one protein, HCON_00074590, identified via TPP (cf. UniProt accession code: A0A7I5E8V5).”
BackgroundMethodInfluentialExperimental and data analysis advances in thermal proteome profiling
Figueroa‐Navedo, A. M., & Ivanov, A. R. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100717 · Cited by 13
Ligand interaction landscape of transcription factors and essential enzymes in E. coli
Peng, H., Kotelnikov, S., Egbert, M. E., Ofaim, S., Stevens, G. C., Phanse, S., Saccon, T. D., Ignatov, M., Dutta, S., Istace, Z., et al. (2025) · Cell · doi:10.1016/j.cell.2025.01.003 · Cited by 14
COVID-19: Nanomedicine Uncovers Blood-Clot Mystery
Saei, A. A., Sharifi, S., & Mahmoudi, M. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00425 · Cited by 15
Reproducibility in the unfolding process of protein induced by an external electric field
Sinelnikova, A., Mandl, T., Östlin, C., Grånäs, O., Brodmerkel, M. N., Marklund, E. G., & Caleman, C. (2020) · Chemical Science · doi:10.1039/d0sc06008a · Cited by 13
Metabolomics paves the way for improved drug target identification
Garana, B. B., & Graham, N. A. (2022) · Molecular Systems Biology · doi:10.15252/msb.202210914 · Cited by 12
“Proteomic approaches to drug target identification have also been successful at defining drug–target relationships, including thermal proteome profiling which exploits the increased resistance to heat-induced protein unfolding that occurs upon drug binding (Savitski et al, 2014).”
BackgroundYu, C., Chen, X., Xu, W., Li, S., Chai, Q., & Zhang, Y. (2023) · PROTEOMICS · doi:10.1002/pmic.202200281 · Cited by 13
“In order to conform SPP method to other modification-free proteomic technology, we primarily adopted the statistical criteria for the generation of normalization curves in TPP method [8], including Benjiamini–Hochberg (BH) corrected p-value which select the proteins whose BH-corrected p-values is less than 0.”
MethodResultInfluentialDetergents: Friends not foes for high‐performance membrane proteomics toward precision medicine
Zhang, X. (2016) · PROTEOMICS · doi:10.1002/pmic.201600209 · Cited by 14
“The initial protocols measured proteins with Western blot (2013) [151] and with TMT-based bottom-up proteomics following in-gel digestion (2014) [150, 153]; both were based on aqueous/urea cell lysis thus limited to soluble proteins [150, 151].”
MethodUsmanova, D. R., Plata, G., & Vitkup, D. (2021) · Genome Biology and Evolution · doi:10.1093/gbe/evab006 · Cited by 15
“sapiens proteins [12], and several proteome-wide datasets characterizing protein aggregation and misinteraction propensities in several species [13-17].”
BackgroundSchnöder, L., Tomic, I., Schwindt, L., Helm, D., Rettel, M., Schulz‐Schaeffer, W., Krause, E., Rettig, J., Fassbender, K. C., & Liu, Y. (2021) · The FASEB Journal · doi:10.1096/fj.202100017r · Cited by 12
Quantitative proteomics of model organisms
Feng, Y., Cappelletti, V., & Picotti, P. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.09.004 · Cited by 13
The Molecular Basis of Amino Acids Sensing
Jiang, C., Tan, X., Jin, J., & Wang, P. (2025) · Advanced Science · doi:10.1002/advs.202501889 · Cited by 18
Laraia, L., Garivet, G., Foley, D. J., Kaiser, N., Müller, S., Zinken, S., Pinkert, T., Wilke, J., Corkery, D., Pahl, A., et al. (2019) · Angewandte Chemie · doi:10.1002/ange.201913712 · Cited by 12
Lizano-Fallas, V., del Amor, A. C., & Cristóbal, S. (2023) · Toxics · doi:10.3390/toxics11020189 · Cited by 12
“Based on that finding, the thermal proteome profiling (TPP) method could systematically track all changes in proteome thermal stability upon binding to a compound by mass spectrometry and specifically identify a few true targets among several thousands of proteins [11].”
BackgroundIacobucci, I., Manna, S. L., Cipollone, I., Monaco, V., Canè, L., & Cozzolino, F. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071997 · Cited by 12
“For example, thermal proteome profiling (TPP) [62] has been used to study metallo- drug targets [63].”
BackgroundInfluentialThermal Proteome Profiling for Drug Target Identification and Probing of Protein States
Sauer, P., & Bantscheff, M. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3457-8_5 · Cited by 12
Self-citationMitochondrial Thermogenesis Can Trigger Heat Shock Response in the Nucleus
Kang, M., Kim, H.-R., Lee, H. Y., Kwak, C. S., Koh, H. K., Kang, B. H., Roe, J., & Rhee, H. (2024) · ACS Central Science · doi:10.1021/acscentsci.3c01589 · Cited by 13
Advancing target validation with PROTAC technology
Spitz, M. L., Kashkush, A., & Benhamou, R. I. (2025) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2025.2490248 · Cited by 14
“Chernobrovkin et al. used CETSA MS combined with quantitative proteomics to study target engagement and functional readout of a number of molecular glues and PROTACs [78,79].”
Label-free technologies for target identification and validation
Li, J., Xu, H., West, G. M., & Jones, L. H. (2016) · MedChemComm · doi:10.1039/c6md00045b · Cited by 13
Kinetic Insights into the Binding between the nSH3 Domain of CrkII and Proline-Rich Motifs in cAbl
Zeng, D., Bhatt, V. S., Shen, Q., & Cho, J. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.09.029 · Cited by 13
Mass spectrometry-based methods for structural biology on a proteome-wide scale
Jones, L. M. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190794 · Cited by 14
Recent advances in bioanalytical methods to measure proteome stability in cells
Zhang, S., Greening, D. W., & Hong, Y. (2021) · The Analyst · doi:10.1039/d0an01547d · Cited by 13
Global Mapping of Metalloproteomes
Zeng, X., Cheng, Y., & Wang, C. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00404 · Cited by 15
Bailey, M. A., Tang, Y., Park, H.-J., & Fitzgerald, M. C. (2023) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.2c00248 · Cited by 12
El‐Baba, T. J., Raab, S. A., Buckley, R., Brown, C. J., Lutomski, C. A., Henderson, L. W., Woodall, D. W., Shen, J., Trinidad, J. C., Niu, H., et al. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c00772 · Cited by 14
Pan, S., Jang, S., Liew, S. S., Fu, J., Wang, D., Lee, J., & Yao, S. Q. (2017) · Angewandte Chemie · doi:10.1002/ange.201710856 · Cited by 12
Target Discovery Using Thermal Proteome Profiling
Sridharan, S., Günthner, I., Becher, I., Savitski, M. M., & Bantscheff, M. (2019) · Wiley eBooks · doi:10.1002/9781118970195.ch11 · Cited by 14
Self-citationDrug mechanism enrichment analysis improves prioritization of therapeutics for repurposing
Garana, B. B., Joly, J. H., Delfarah, A., Hong, H., & Graham, N. A. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05343-8 · Cited by 12
“However, improved 613 annotation of drug MOAs and targets, potentially through newer approaches including 614 metabolomics [66] and proteomics [67], will improve the power of DMEA.”
BackgroundZhang, X., Ruan, C., Wang, Y., Wang, K., Liu, X., Lyu, J., & Ye, M. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c00072 · Cited by 11
Large-scale characterization of drug mechanism of action using proteome-wide thermal shift assays
Vranken, J. G. V., Li, J., Mintseris, J., Wei, T.-Y., Sniezek, C. M., Gadzuk-Shea, M. M., Gygi, S. P., & Schweppe, D. K. (2024) · eLife · doi:10.7554/elife.95595.3 · Cited by 18
Poly-pharmacology of existing drugs: How to crack the code?
Mouysset, B., Grand, M. L., Camoin, L., & Pasquier, E. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216800 · Cited by 13
Analysis of Limited Proteolysis-Coupled Mass Spectrometry Data
Nagel, L., Großbach, J., Cappelletti, V., Dörig, C., Picotti, P., & Beyer, A. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.100934 · Cited by 10
Hengst, J. A., Dick, T. E., Smith, C. D., & Yun, J. K. (2020) · Cancer Biology & Therapy · doi:10.1080/15384047.2020.1798696 · Cited by 12
Utilizing thermal proteome profiling to identify the molecular targets of anti-leishmanial compounds
Corpas‐López, V., & Wyllie, S. (2021) · STAR Protocols · doi:10.1016/j.xpro.2021.100704 · Cited by 11
Michele, M. D., Stes, E., Vandermarliere, E., Arora, R., Astorga‐Wells, J., Vandenbussche, J., van Heerde, E., Zubarev, R. A., Bonnet, P., Linders, J. T. M., et al. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00282 · Cited by 11
Identification of Protein Targets of Bioactive Small Molecules Using Randomly Photomodified Probes
Šimon, P., Knedlík, T., Blažková, K., Dvořáková, P., Březinová, A., Kostka, L., Šubr, V., Konvalinka, J., & Šácha, P. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00791 · Cited by 11
The rise of proteome‐wide biophysics
Mateus, A., Savitski, M. M., & Piazza, I. (2021) · Molecular Systems Biology · doi:10.15252/msb.202110442 · Cited by 10
Self-citationLi, S., Wang, F., Zhang, G., & Chou, T. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040764 · Cited by 11
“The proteome-wide cellular thermal shift assay (CETSA) is used to determine protein interaction changes in the presence of drug [57,58].”
MethodGuo, P., Jiang, M., Hu, S., Jiang, Q., Limin, L. I., Wu, J., Ma, Y., & Wu, Z. (2026) · Chinese Medicine · doi:10.1186/s13020-025-01194-y · Cited by 18
AI and Machine Learning for Proteomics-Driven Drug Discovery: Methods, Tools, and Best Practices
Basak, S. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48050532 · Cited by 10
Metadata
- Authors
- Savitski, M. M., Reinhard, F. B. M., Franken, H., Werner, T., Savitski, M. F., Eberhard, D., Molina, D. M., Jafari, R., Dovega, R. B., Klaeger, S., Kuster, B., Nordlund, P., Bantscheff, M., & Drewes, G.
- Affiliations
- GlaxoSmithKline (Germany) (DE)
- Karolinska Institutet (SE)
- German Cancer Research Center (DE)
- Department of Proteomics and Bioanalytics, Technische Universität München, Emil Erlenmeyer Forum 5, Freising, Germany.
- Division of Biophysics, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
- Corresponding author
- Savitski, Mikhail M.
- Reinhard, Friedrich B. M.
- Bantscheff, Marcus
- Drewes, Gerard
- ORCID
- Venue
- Science
- Published
- 2014-10-03
- Volume
- 346
- Issue
- 6205
- Pages
- 1255784-1255784
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2131321938
- Cited by
- 1,187
- References
- 41
- Citations by year
- 2026: 119 · 2025: 138 · 2024: 148 · 2023: 130 · 2022: 116 · 2021: 132 · 2020: 95 · 2019: 85 · 2018: 67 · 2017: 56 · 2016: 54 · 2015: 39 · 2014: 5
- FWCI
- 22.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Physical Sciences › Chemistry › Physical and Theoretical Chemistry › thermodynamics and calorimetric analyses
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Keywords
- thermal proteome profiling, drug-target engagement, protein thermal stability, kinase inhibitors, staurosporine, ferrochelatase, vemurafenib, alectinib, phototoxicity, dasatinib, BCR-ABL, cancer drug targets
- MeSH terms
- Adenosine Triphosphatases, Antineoplastic Agents, Hot Temperature, Humans, Ligands, Protein Binding, Protein Denaturation, K562 Cells, Proteome, Proteomics, Protein Stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.